4.6 Article

Predictors of persistent ADHD: An 11-year follow-up study

期刊

JOURNAL OF PSYCHIATRIC RESEARCH
卷 45, 期 2, 页码 150-155

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychires.2010.06.009

关键词

ADHD; Persistence; Predictors; Longitudinal; Young adult

资金

  1. National Institute of Child Health and Human Development (NICHD) [5R01HD036317-10]
  2. Lilly Foundation Fund
  3. Pediatric Psychopharmacology Philanthropic Fund
  4. Alza
  5. AstraZeneca
  6. Bristol Myers Squibb
  7. Eli Lilly and Co.
  8. Janssen Pharmaceuticals Inc.
  9. McNeil
  10. Merck
  11. Organon
  12. Otsuka
  13. Shire
  14. NIMH
  15. NICHD
  16. Fundacion Areces
  17. Medice Pharmaceuticals
  18. Spanish Child Psychiatry Association
  19. Abbott
  20. Celltech
  21. Cephalon
  22. Esai
  23. Forest
  24. Glaxo
  25. Gliatech
  26. Janssen
  27. NARSAD
  28. NIDA
  29. New River
  30. Novartis
  31. Noven
  32. Neurosearch
  33. Pfizer
  34. Pharmacia
  35. Prechter Foundation
  36. Stanley Foundation
  37. UCB Pharma, Inc.
  38. Wyeth
  39. Eli Lilly
  40. Ortho-McNeil
  41. Shire Development
  42. National Institutes of Health

向作者/读者索取更多资源

Objective: Despite the existence of several follow-up studies of children with ADHD followed up into adulthood, there is limited information on whether patterns of persistence and remission in ADHD can be predicted over the long term. The main aim of this study was to evaluate predictors of persistence of ADHD in a large sample of boys with and without ADHD followed prospectively for 11 years into young adulthood. Method: Subjects were Caucasian, non-Hispanic boys with (N = 110) and without (N = 105) ADHD who were 6-17 years old at the baseline assessment (mean age 11 years) and 15 to 31 years old at the follow-up assessment (mean age 22 years). Subjects were comprehensively and blindly assessed with structured diagnostic interviews and assessments of cognitive, social, school, and family functioning. Results: At the 11-year follow-up, 78% of children with ADHD continued to have a full (35%) or a partial persistence (subsyndromal (22%), impaired functioning (15%), or remitted but treated (6%)). Predictors of persistence were severe impairment of ADHD, psychiatric comorbidity, and exposure to maternal psychopathology at baseline. Conclusions: These findings prospectively confirm that persistence of ADHD over the long term is predictable from psychosocial adversity and psychiatric comorbidity ascertained 11 years earlier. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据